Document:

Letter Agreement with Walter C. Herlihy

 Exhibit 10.17 

 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 March 21, 2011 
 Walter Herlihy 
 12 Edgemoor Rd 
 Gloucester, MA 01930 
 Dear Walt, 
 As you are aware, on April 3, 2001 you were awarded 50,000 stock options at an exercise price of $2.66. Pursuant to the details of that award and the Company’s overall Stock Option Plan that has
been approved by our shareholders, those options expire 10 years from the date of grant, or April 3, 2011. 
 Effective, March 17,
2011 through the close of business on March 31, 2011, we expect to be in an open window for insider trading of Repligen stock. The window will then be closed until such time as the results of our fiscal year are announced to the public. This
date has yet to be established, but in any event will be after the expiration of this stock option award. 
 While you are under no obligation
to exercise these options prior to expiration, and should consult with your own advisors regarding the tax and other consequences of your transaction, we did want to make you aware of an alternative method of exercise that is being made available.

 You may exercise these options as you always have in the past, should you desire, during the open trading window. This includes being able to
do a same day sale, cashless exercise, or straight exercise for cash. 
 Alternatively, you may elect to agree to surrender your options and
receive cash, in lieu of exercise. The amount paid to you will be the difference, on March 30, 2011, between the then market value of the stock and your exercise price of $2.66, times the number of shares you look to wish to surrender. By way
of example, if the market value on March 30, 2011 is $3.66, you can expect to receive $1.00 per share ($3.66 - $2.66). 
 If you wish to
avail yourself of this option, please execute the attached instructions no later than March 24, 2011. 
 Should you have any questions,
please do not hesitate to contact me. 
 Best regards, 
 Bill Kelly 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 SURRENDER OF STOCK OPTIONS FOR CASH IN LIEU OF EXERCISE 

I, Walter Herlihy, hereby and irrevocably surrender 50,000 stock options, granted on April 3, 2001 with an exercise price of $2.66. I agree to
receive cash payment from the Company equal to the difference between the market value of Repligen’s stock on March 30, 2011 and the exercise price of $2.66. I recognize that if the market value of the Company stock is below $2.66 on
March 30, 2011, no cash payment will be made by the Company. 
 /s/ Walter Herlihy 
 Signature 
 March 24, 2011 
 DateLetter Agreement with James R. Rusche

 Exhibit 10.18 

 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 March 21, 2011 
 James Rusche 
 18 Brigham Rd. 
 Framingham, MA 01701 
 Dear Jim, 
 As you are aware, on April 3, 2001 you were awarded 25,000 stock options at an exercise price of $2.66. Pursuant to the details of that award and the Company’s overall Stock Option Plan that has
been approved by our shareholders, those options expire 10 years from the date of grant, or April 3, 2011. 
 Effective, March 17,
2011 through the close of business on March 31, 2011, we expect to be in an open window for insider trading of Repligen stock. The window will then be closed until such time as the results of our fiscal year are announced to the public. This
date has yet to be established, but in any event will be after the expiration of this stock option award. 
 While you are under no obligation
to exercise these options prior to expiration, and should consult with your own advisors regarding the tax and other consequences of your transaction, we did want to make you aware of an alternative method of exercise that is being made available.

 You may exercise these options as you always have in the past, should you desire, during the open trading window. This includes being able to
do a same day sale, cashless exercise, or straight exercise for cash. 
 Alternatively, you may elect to agree to surrender your options and
receive cash, in lieu of exercise. The amount paid to you will be the difference, on March 30, 2011, between the then market value of the stock and your exercise price of $2.66, times the number of shares you look to wish to surrender. By way
of example, if the market value on March 30, 2011 is $3.66, you can expect to receive $1.00 per share ($3.66 - $2.66). 
 If you wish to
avail yourself of this option, please execute the attached instructions no later than March 24, 2011. 
 Should you have any questions,
please do not hesitate to contact me. 
 Best regards, 
 Bill Kelly 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 SURRENDER OF STOCK OPTIONS FOR CASH IN LIEU OF EXERCISE 

I, James Rusche, hereby and irrevocably surrender 18,000 stock options, granted on April 3, 2001 with an exercise price of $2.66. I agree to receive
cash payment from the Company equal to the difference between the market value of Repligen’s stock on March 30, 2011 and the exercise price of $2.66. I recognize that if the market value of the Company stock is below $2.66 on
March 30, 2011, no cash payment will be made by the Company. 
 /s/ James Rusche 
 Signature 
 March 24, 2011 
 DateLetter Agreement with Daniel P. Witt

 Exhibit 10.19 

 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 March 21, 2011 
 Dan Witt 
 28 Oak Street, Apt. #1 
 Charlestown, MA 02129 
 Dear Dan, 
 As you are aware, on April 3, 2001 you were awarded 10,000 stock options at an exercise price of $2.66. Pursuant to the details of that award and the Company’s overall Stock Option Plan that has
been approved by our shareholders, those options expire 10 years from the date of grant, or April 3, 2011. 
 Effective, March 17,
2011 through the close of business on March 31, 2011, we expect to be in an open window for insider trading of Repligen stock. The window will then be closed until such time as the results of our fiscal year are announced to the public. This
date has yet to be established, but in any event will be after the expiration of this stock option award. 
 While you are under no obligation
to exercise these options prior to expiration, and should consult with your own advisors regarding the tax and other consequences of your transaction, we did want to make you aware of an alternative method of exercise that is being made available.

 You may exercise these options as you always have in the past, should you desire, during the open trading window. This includes being able to
do a same day sale, cashless exercise, or straight exercise for cash. 
 Alternatively, you may elect to agree to surrender your options and
receive cash, in lieu of exercise. The amount paid to you will be the difference, on March 30, 2011, between the then market value of the stock and your exercise price of $2.66, times the number of shares you look to wish to surrender. By way
of example, if the market value on March 30, 2011 is $3.66, you can expect to receive $1.00 per share ($3.66 - $2.66). 
 If you wish to
avail yourself of this option, please execute the attached instructions no later than March 24, 2011. 
 Should you have any questions,
please do not hesitate to contact me. 
 Best regards, 
 Bill Kelly 

			
	

	  	 Repligen Corporation

41 Seyon Street
 Building #1, Suite
100
 Waltham, MA 02453
 Telephone:
781-250-0111
 Telefax: 781-250-0115

  

			
	 	  	

 SURRENDER OF STOCK OPTIONS FOR CASH IN LIEU OF EXERCISE 

I, Dan Witt, hereby and irrevocably surrender 10,000 stock options, granted on April 3, 2001 with an exercise price of $2.66. I agree to receive cash
payment from the Company equal to the difference between the market value of Repligen’s stock on March 30, 2011 and the exercise price of $2.66. I recognize that if the market value of the Company stock is below $2.66 on March 30,
2011, no cash payment will be made by the Company. 
 /s/ Dan Witt 
 Signature 
 March 24, 2011 
 DatePurchase Agreement for the Company's 8.25% Senior Notes

 Exhibit 10.1 
  

 
  

AEP INDUSTRIES INC. 
 (a Delaware corporation) 
 $200,000,000 8 1/4% Senior Notes due 2019 

PURCHASE AGREEMENT 
 Dated:
April 7, 2011 
  
  

 

 AEP INDUSTRIES INC. 
 (a Delaware corporation) 
 $200,000,000 

8 
1/4% Senior Notes due 2019 
 PURCHASE AGREEMENT 
 April 7, 2011 

MERRILL LYNCH, PIERCE, FENNER & SMITH 

INCORPORATED 
 As Representative of the Initial Purchasers 
 One Bryant Park 

New York, New York 10036 
 Ladies and Gentlemen:

 AEP Industries Inc., a Delaware corporation (the “Company”), confirms its agreement with
Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and the other several Initial Purchasers named in Schedule A (the “Initial Purchasers”, which term shall also include any initial purchaser substituted
as hereinafter provided in Section 11 hereof), for whom Merrill Lynch is acting as representative (in such capacity, the “Representative”), with respect to the issue and sale by the Company and the purchase by the Initial Purchasers,
acting severally and not jointly, of the respective principal amounts set forth in Schedule A hereto of $200,000,000 aggregate principal amount of the Company’s 8 1/4% Senior Notes due 2019 (the “Securities”). The Securities
are to be issued pursuant to an indenture dated as of April 18, 2011 (the “Indenture”) between the Company and The Bank of New York Mellon, as trustee (the “Trustee”). Securities issued in book-entry form will be issued to
Cede & Co. as nominee of The Depository Trust Company (“DTC”) pursuant to a letter of representations, to be dated as of the Closing Date (as defined in Section 2(b) hereof) (the “DTC Agreement”), among the Company,
the Trustee and DTC. 
 The Company understands that the Initial Purchasers propose to make an offering of the Securities
on the terms and in the manner set forth herein and agrees that the Initial Purchasers may resell, subject to the conditions set forth herein, all or a portion of the Securities to purchasers (“Subsequent Purchasers”) at any time after
this Agreement has been executed and delivered (the first time when sales of the Securities are made is referred to as the “Time of Sale”). The Securities are to be offered and sold through the Initial Purchasers without being registered
under the Securities Act of 1933, as amended (the “Securities Act”, which term, as used herein, includes the rules and regulations of the Commission promulgated thereunder), in reliance upon exemptions therefrom. Pursuant to the terms
of the Securities and the Indenture, investors that acquire Securities may only resell or otherwise transfer such Securities if such Securities are hereafter registered under the Securities Act or if an exemption from the registration requirements
of the Securities Act is available (including the exemptions afforded by Rule 144A (“Rule 144A”) or Regulation S (“Regulation S”) of the rules and regulations promulgated under the Securities Act by the
Securities and Exchange Commission (the “Commission”)). 
 The holders of the Securities will be entitled to the
benefits of a registration rights agreement, to be dated as of April 18, 2011 (the “Registration Rights Agreement”), among the Company and the Initial Purchasers, pursuant to which the Company will agree to file with the Securities
and Exchange Commission (the “Commission”), under the circumstances set forth therein, (i) a registration statement under the Securities Act relating to another series of debt securities of the Company with terms

 
substantially identical to the Securities (the “Exchange Securities”) to be offered in exchange for the Securities (the “Exchange Offer”) and (ii) to the extent required
by the Registration Rights Agreement, a shelf registration statement pursuant to Rule 415 of the Securities Act relating to the resale by certain holders of the Securities, and in each case, to use their commercially reasonable efforts to cause such
registration statements (any such registration statement, a “Registration Statement”) to be declared effective. 
 The
Company has prepared and delivered to each Initial Purchaser copies of a preliminary offering memorandum dated April 4, 2011 (the “Preliminary Offering Memorandum”) and has prepared and delivered to each Initial Purchaser copies of a
Pricing Supplement, dated April 7, 2011 (the “Pricing Supplement”), describing the terms of the Securities, each for use by such Initial Purchaser in connection with its solicitation of purchases of, or offering of, the Securities.
The Preliminary Offering Memorandum and the Pricing Supplement are herein referred to as the “Pricing Disclosure Package.” Promptly after this Agreement is executed and delivered, the Company will prepare and deliver to each Initial
Purchaser a final offering memorandum dated the date hereof (the “Final Offering Memorandum”). “Offering Memorandum” means, with respect to any date or time referred to in this Agreement, the most recent offering memorandum
(whether the Preliminary Offering Memorandum or the Final Offering Memorandum, or any amendment or supplement to either such document), including exhibits thereto, which has been prepared and delivered by the Company to the Initial Purchasers in
connection with their solicitation of purchases of, or offering of, the Securities. 
 This Agreement, the Registration Rights
Agreement, the DTC Agreement, the Securities, the Exchange Securities and the Indenture are referred to herein as the “Transaction Documents.” 
 In connection with the offering of the Securities by the Company, the Company has commenced a tender offer to purchase for cash any and all of the $160,160,000 aggregate principal amount outstanding of
the Company’s 7.875% Senior Notes due 2013 (the “Senior Notes”) and a solicitation of consents (the “Consents”) from the holders of the Senior Notes to amend the indenture among the Company and The Bank of New York, as
trustee, dated as of March 18, 2005 (the “Senior Notes Indenture”) relating to the Senior Notes pursuant to its Offer to Purchase and Consent Solicitation Statement dated April 4, 2011 (the “Tender Offer and Consent
Solicitation”). As described in the Offering Memorandum, a portion of the proceeds from the offering of the Securities received by the Company is to be used to repurchase the Notes tendered in the Tender Offer and Consent Solicitation and to
repay related fees and expenses. 
 SECTION 1. Representations and Warranties by the Company. 

(a) Representations and Warranties. The Company hereby represents, warrants and covenants to each Initial Purchaser as of the date
hereof and as of the Closing Date referred to in Section 2(b) hereof, and agrees with each Initial Purchaser, as follows: 
 (i) The Pricing Disclosure Package and Offering Memorandum. Neither the Pricing Disclosure Package, as of the Time of Sale, nor the Final Offering Memorandum, as of its date or (as amended or
supplemented in accordance with Section 3(c), as applicable) as of the Closing Date, contains or represents an untrue statement of a material fact or omits to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; provided that this representation, warranty and agreement shall not apply to statements in or omissions from the Pricing Disclosure Package, the Final Offering Memorandum or any
amendment or supplement thereto made in reliance upon and in conformity with information furnished to the Company in writing by any Initial Purchaser 

  
 2 

 
through the Representative expressly for use in the Pricing Disclosure Package, the Final Offering Memorandum or amendment or supplement thereto, as the case may be. The Pricing Disclosure
Package contains, and the Final Offering Memorandum will contain, all the information specified in, and meeting the requirements of, Rule 144A. The Company has not distributed and will not distribute, prior to the later of the Closing Date and the
completion of the Initial Purchasers’ distribution of the Securities, any offering material in connection with the offering and sale of the Securities other than the Pricing Disclosure Package and the Final Offering Memorandum. 

(ii) Company Additional Written Communications. The Company has not prepared, made, used, authorized, approved or
distributed and will not prepare, make, use, authorize, approve or distribute any written communication (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities other than
(i) the Pricing Disclosure Package, (ii) the Final Offering Memorandum and (iii) any electronic road show or other written communications, in each case used in accordance with Section 3(c). Each such communication by the Company
or its agents and representatives pursuant to clause (iii) of the preceding sentence (each, a “Company Additional Written Communication”), when taken together with the Pricing Disclosure Package, did not as of the Time of Sale, and at
the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided
that this representation, warranty and agreement shall not apply to statements in or omissions from each such Company Additional Written Communication made in reliance upon and in conformity with information furnished to the Company in writing by
any Initial Purchaser through the Representative expressly for use in any Company Additional Written Communication. 
 (iii) Independent Accountants. KPMG LLP, who has expressed its opinion with respect to the financial statements (including the related notes thereto) and supporting schedules included in the
Pricing Disclosure Package and the Final Offering Memorandum are independent registered public accountants with respect to the Company and its subsidiaries within the meaning of the Securities Act, the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), and the rules of the Public Company Accounting Oversight Board and any non-audit services provided by KPMG LLP to the Company have been approved by the Audit Committee of the Board of Directors of the Company.

 (iv) Financial Statements. The consolidated financial statements, together with the related schedules
and notes, included in the Pricing Disclosure Package and the Final Offering Memorandum present fairly in all material respects the financial position of the Company and its consolidated subsidiaries as of and at the dates indicated and their
results of operations, stockholders’ equity and cash flows as of the dates and for the periods specified; said financial statements have been prepared in conformity with generally accepted accounting principles (“GAAP”) applied on a
consistent basis throughout the periods involved, except as may be expressly stated in the related notes thereto. The supporting schedules, if any, included in the Pricing Disclosure Package and the Final Offering Memorandum present fairly in
accordance with GAAP the information required to be stated therein. The selected financial data and the summary financial information included in the Pricing Disclosure Package and the Final Offering Memorandum present fairly the information shown
therein and have been compiled on a basis consistent with that of the audited financial statements included in the Pricing Disclosure Package and the Final Offering Memorandum. The statistical and market-related data and forward-looking statements
included in the Pricing Disclosure Package and the Final Offering Memorandum are based on or derived from sources that the Company and its subsidiaries believe 

  
 3 

 
to be reliable and accurate in all material respects and represent their good faith estimates that are made on the basis of data derived from such sources. 

(v) No Material Adverse Change. Since the respective dates as of which information is given in the Pricing
Disclosure Package and the Final Offering Memorandum, except as otherwise stated therein, (A) there has been no material adverse change, or any development that could reasonably be expected to result in a material adverse change, in the
condition, financial or otherwise, or in the earnings, business, operations or prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a “Material Adverse
Effect”), (B) there have been no transactions entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as
one enterprise, and (C) there has been no dividend or distribution of any kind declared, paid or made by the Company or, except for dividends paid to the Company or other subsidiaries, any of its subsidiaries on any class of capital stock or
repurchase or redemption by the Company or any of its subsidiaries of any class of capital stock. 
 (vi) Good
Standing of the Company. The Company has been duly organized and is validly existing as a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to
conduct its business as described in the Pricing Disclosure Package and the Final Offering Memorandum and to enter into and perform its obligations under this Agreement, the Indenture, the Securities, the Exchange Securities, the Registration Rights
Agreement and the DTC Agreement; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or
leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not result in a Material Adverse Effect. 
 (vii) Good Standing of Subsidiaries. The Company does not own or control, directly or indirectly, any corporation, association, partnership or other entity other than the subsidiaries listed in
Schedule C to this Agreement (each such corporation, association, partnership or other entity, a “Subsidiary”). Each Subsidiary has been duly organized and is validly existing as an entity in good standing under the laws of the
jurisdiction of its organization, has the requisite power and authority to own, lease and operate its properties and to conduct its business as described in the Pricing Disclosure Package and the Final Offering Memorandum and is duly qualified as a
foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to
qualify or to be in good standing would not, singly or in the aggregate, result in a Material Adverse Effect; except as otherwise disclosed in the Pricing Disclosure Package and the Final Offering Memorandum (including under the caption
“Description of Other Indebtedness”), all of the issued and outstanding capital stock or other ownership interest of each Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company,
directly or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity; and none of the outstanding shares of capital stock of each Subsidiary was issued in violation of any preemptive or
similar rights of any securityholder of such Subsidiary. 
 (viii) Capitalization and Other Capital Stock
Matters. The authorized, issued and outstanding capital stock of the Company is as set forth in the financial statements, including the schedules and notes, included or incorporated in the Pricing Disclosure Package and the Final Offering
Memorandum (except for subsequent issuances, if any, pursuant to this Agreement, 

  
 4 

 
pursuant to reservations, agreements, rights plans, employee benefit plans referred to in the Pricing Disclosure Package and the Final Offering Memorandum or pursuant to the exercise of
convertible securities or options referred to in the Pricing Disclosure Package and the Final Offering Memorandum). At January 31, 2011, on a consolidated basis, after giving pro forma effect to the issuance and sale of the Securities
pursuant hereto and the application of the net proceeds from the sale of the Securities in the manner described under the caption “Use of Proceeds” in the Pricing Disclosure Package and the Final Offering Memorandum, the Company would have
the capitalization as set forth under the “As Adjusted” column of the table in the Final Offering Memorandum under the caption “Capitalization”. The shares of issued and outstanding capital stock of the Company have been duly
authorized and validly issued and are fully paid and non-assessable; and none of the outstanding shares of capital stock of the Company was issued in violation of the preemptive or other similar rights of any securityholder of the Company.

 (ix) Authorization of Agreement. This Agreement has been duly authorized, executed and delivered by the
Company, and is a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating
to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and is subject, as to enforceability, to general principles of equity (regardless of whether enforcement is considered in
a proceeding in equity or at law) and except to the extent that the enforceability of indemnification and contribution provisions may be limited by federal and state securities laws or public policy. 

(x) Authorization of the Indenture. The Indenture has been duly authorized by the Company and, when executed and
delivered by the Company and the Trustee, will constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency
(including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of
equity (regardless of whether enforcement is considered in a proceeding in equity or at law). 
 (xi)
Authorization of the Securities and the Exchange Securities. (A) The Securities have been duly authorized and, at the Closing Date (as defined in Section 2(b) hereof), will have been duly executed by the Company and, when
authenticated, issued and delivered in the manner provided for in the Indenture and delivered against payment of the purchase price therefor as provided in this Agreement, will constitute valid and binding obligations of the Company, enforceable
against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws
affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law), and will be in the form
contemplated by, and entitled to the benefits of, the Indenture; and (B) the Exchange Securities have been duly and validly authorized for issuance by the Company, and when issued and authenticated in accordance with the terms of the Indenture,
the Registration Rights Agreement and the Exchange Offer (as defined in the Registration Rights Agreement), will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as the
enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except
as 

  
 5 

 
enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in equity or at law), and will be in the form contemplated by, and
entitled to the benefits of, the Indenture. 
 (xii) Description of the Securities, the Indenture and the
Registration Rights Agreement. The Securities, the Exchange Securities, the Indenture and the Registration Rights Agreement will conform in all material respects to the respective statements relating thereto contained in the Pricing Disclosure
Package and the Final Offering Memorandum. 
 (xiii) The Registration Rights Agreement and the DTC
Agreement. At the Closing Date (as defined in Section 2(b) hereof), each of the Registration Rights Agreement and the DTC Agreement will be duly authorized, executed and delivered by, and, when duly executed and delivered in accordance with
its terms by each of the parties thereto, will be a valid and binding agreement of, the Company, enforceable in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all
laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether
enforcement is considered in a proceeding in equity or at law). 
 (xiv) Absence of Defaults and
Conflicts. Neither the Company nor any Subsidiary is in violation of its charter or by-laws or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed
of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any Subsidiary is a party or by which it or any of them may be bound, or to which any of the property or assets of the Company or any Subsidiary
is subject (collectively, “Agreements and Instruments”) except for such defaults that would not, singly or in the aggregate, result in a Material Adverse Effect; and the issuance and delivery of the Securities and the Exchange Securities,
and the execution, delivery and performance of this Agreement, the Indenture, the Registration Rights Agreement, the DTC Agreement and any other agreement or instrument entered into or issued or to be entered into or issued by the Company in
connection with the transactions contemplated hereby or thereby or in the Pricing Disclosure Package and the Final Offering Memorandum and compliance by the Company with its obligations thereunder, and the consummation of the transactions
contemplated herein or therein and in the Pricing Disclosure Package and the Final Offering Memorandum (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described in the Pricing
Disclosure Package and the Final Offering Memorandum under the caption “Use of Proceeds”) have been duly authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time
or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any lien, charge or encumbrance upon any property or assets of the Company or any Subsidiary
pursuant to, the Agreements and Instruments except for such conflicts, breaches or defaults or Repayment Events or liens, charges or encumbrances that, singly or in the aggregate, would not result in a Material Adverse Effect, nor will such action
result in any violation of the provisions of the charter or by-laws of the Company or any Subsidiary or any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic
or foreign, having jurisdiction over the Company or any Subsidiary or any of their assets, properties or operations. As used herein, a “Repayment Event” means any event or condition which gives, or with the giving of notice or lapse of
time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the
Company or any Subsidiary. 

  
 6 

 (xv) Absence of Labor Dispute. No labor dispute with the employees of
the Company or any Subsidiary exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or any Subsidiary’s principal suppliers,
manufacturers, customers or contractors, which, in either case, would result in a Material Adverse Effect. 

(xvi) Compliance with Labor Laws. Except as otherwise disclosed in the Pricing Disclosure Package or the Final
Offering Memorandum or as would not, singly or in the aggregate, result in a Material Adverse Effect, (i) there is (A) no unfair labor practice complaint pending or, to the best of the Company’s knowledge, threatened against the
Company or any of its subsidiaries before the National Labor Relations Board, and no grievance or arbitration proceeding arising out of or under collective bargaining agreements pending, or to the best of the Company’s knowledge, threatened,
against the Company or any of its subsidiaries, (B) no strike, labor dispute, slowdown or stoppage pending or, to the best of the Company’s knowledge, threatened against the Company or any of its subsidiaries and (C) no union
representation question existing with respect to the employees of the Company or any of its subsidiaries and, to the best of the Company’s knowledge, no union organizing activities taking place and (ii) there has been no violation of any
federal, state or local law relating to discrimination in hiring, promotion or pay of employees or of any applicable wage or hour laws. 
 (xvii) Absence of Proceedings. Except as otherwise disclosed in the Pricing Disclosure Package and the Final Offering Memorandum, there is no action, suit, proceeding, inquiry or investigation
before or brought by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company, threatened, against or affecting the Company or any Subsidiary which would reasonably be expected to result in a
Material Adverse Effect, or which might materially and adversely affect the properties or assets of the Company or any Subsidiary or the consummation of the transactions contemplated by this Agreement or the performance by the Company of its
obligations hereunder. The aggregate of all pending legal or governmental proceedings to which the Company or any Subsidiary is a party or of which any of their respective property or assets is the subject which are not described in the Pricing
Disclosure Package and the Final Offering Memorandum, including ordinary routine litigation incidental to the business, could not reasonably be expected to result in a Material Adverse Effect. 

(xviii) Absence of Manipulation. Neither the Company, nor any of its affiliates (as such term is defined in Rule
501 under the Securities Act) (each, an “Affiliate”) has taken, nor will the Company or any Affiliate take, directly or indirectly, any action which is designed to or which has constituted or which would be expected to cause or result in
stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities. 
 (xix) Possession of Intellectual Property. The Company and the Subsidiaries own or possess, or can acquire on reasonable terms, adequate patents, patent rights, licenses, inventions, copyrights,
know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names or other intellectual property (collectively, “Intellectual
Property”) necessary to carry on the business now operated by them, and neither the Company nor any Subsidiary has received any notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to any
Intellectual Property or of any facts or circumstances which would render any Intellectual Property invalid or inadequate to protect the interest of the Company or any Subsidiary therein, and which infringement or conflict (if the subject of any
unfavorable decision, 

  
 7 

 
ruling or finding) or invalidity or inadequacy, singly or in the aggregate, would result in a Material Adverse Effect. 

(xx) Absence of Further Requirements. No filing with, or authorization, approval, consent, license, order,
registration, qualification or decree of, any court or governmental authority or agency is necessary or required in connection with the offering, issuance or sale of the Securities or the Exchange Securities hereunder or for the due execution,
delivery or performance of this Agreement, the Indenture, the Registration Rights Agreement or the DTC Agreement by the Company, or the consummation of the transactions contemplated thereunder and by the Pricing Disclosure Package and the Final
Offering Memorandum, except such as have been already obtained. 
 (xxi) Compliance with Laws. Each of the
Company and the Subsidiaries is in compliance in all material respects with all international, foreign, federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or
authorities, including the interpretation or administration thereof by any governmental authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative orders, directed duties, requests, licenses,
authorizations and permits of, and agreements with, any governmental authority, in each case whether or not having the force of law, except where the failure to so comply would not, singly or in the aggregate, result in a Material Adverse Effect.

 (xxii) Possession of Licenses and Permits. The Company and the Subsidiaries possess such permits,
licenses, approvals, consents and other authorizations (collectively, “Governmental Licenses”) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies necessary to conduct the business now operated by them,
except where the failure so to possess would not, singly or in the aggregate, result in a Material Adverse Effect; the Company and the Subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where the
failure so to comply would not, singly or in the aggregate, result in a Material Adverse Effect; all of the Governmental Licenses are valid and in full force and effect, except where the invalidity of such Governmental Licenses or the failure of
such Governmental Licenses to be in full force and effect would not, singly or in the aggregate, result in a Material Adverse Effect; and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any such Governmental Licenses which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect. 

(xxiii) Title to Property. The Company and the Subsidiaries have good and marketable title to all real property
owned by the Company and the Subsidiaries and good title to all other properties owned by them, in each case free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind, except such as
(A) are described in the Pricing Disclosure Package and the Final Offering Memorandum or (B) do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made of
such property by the Company or any Subsidiary; and all of the leases and subleases material to the business of the Company and the Subsidiaries, considered as one enterprise, and under which the Company or any Subsidiary holds properties described
in the Pricing Disclosure Package and the Final Offering Memorandum, are in full force and effect, and neither the Company nor any Subsidiary has any notice of any material claim of any sort that has been asserted by anyone adverse to the rights of
the Company or any Subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the 

  
 8 

 
rights of the Company or any Subsidiary to the continued possession of the leased or subleased premises under any such lease or sublease. 

(xxiv) Environmental Laws. Except as described in the Pricing Disclosure Package and the Final Offering Memorandum
and except such matters as would not, singly or in the aggregate, result in a Material Adverse Effect, (A) neither the Company nor any Subsidiary is in violation of, and not subject to any known liabilities under, any federal, state, local or
foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to pollution or
protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the release or
threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, “Hazardous Materials”) or to the manufacture,
processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, “Environmental Laws”), (B) the Company and the Subsidiaries have all permits, authorizations and approvals
required under any applicable Environmental Laws and are each in compliance with their requirements, (C) there are no pending or threatened administrative, regulatory or judicial actions, suits, demands, demand letters, claims, liens, notices
of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any Subsidiary or any person or entity whose liability under or pursuant to any Environmental Law the Company or any Subsidiary has
retained or assumed either contractually or by operation of law, (D) neither the Company nor any Subsidiary is conducting or paying for, in whole or in part, any investigation, response or other corrective action pursuant to any Environmental
Law at any site or facility, nor is any of them subject or a party to any order, judgment, decree, contract or agreement which imposes any obligation or liability under any Environmental Law, (E) no lien, charge, encumbrance or restriction has
been recorded pursuant to any Environmental Law with respect to any assets, facility or property owned, operated or leased by the Company or any Subsidiary and (F) there are no events or circumstances that would reasonably be expected to form
the basis of an order for clean-up or remediation, or an action, suit or proceeding by any private party or governmental body or agency, against or affecting the Company or any Subsidiary relating to Hazardous Materials or Environmental Laws.

 (xxv) ERISA Compliance. The Company and any “employee benefit plan” (as defined under the
Employee Retirement Income Security Act of 1974, as amended, and the regulations and published interpretations thereunder (collectively, “ERISA”)) established or maintained by the Company or its “ERISA Affiliates” (as defined
below) are in compliance in all material respects with ERISA. “ERISA Affiliate” means, with respect to the Company, any member of any group of organizations described in Section 414, of the Internal Revenue Code of 1986, as amended,
and the regulations and published interpretations thereunder (the “Code”) of which the Company is a member. No “reportable event” (as defined under ERISA) has occurred or is reasonably expected to occur with respect to any
“employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates. No “employee benefit plan” established or maintained by the Company or any of its ERISA Affiliates, if such “employee benefit
plan” were terminated, would have any “amount of unfunded benefit liabilities” (as defined under ERISA). None of the Company nor any of its ERISA Affiliates has incurred or reasonably expects to incur (i) any liability under
Title IV of ERISA with respect to the termination of, or withdrawal from, any “employee benefit plan”; or (ii) any liability under Sections 412, 4971, 4975 or 4980B of the Code; or (iii) any material liability under
Section 4980B of the Code. Each “employee benefit plan” established or maintained by the Company or 

  
 9 

 
any of its ERISA Affiliates that is intended to be qualified under Section 401 of the Code is so qualified in all material respects and nothing has occurred, whether by action or failure to
act, which would cause the loss of such qualification. 
 (xxvi) Investment Company Act. The Company is
not, and after receipt of payment for the Securities will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended (the “Investment Company Act,” which term, as used herein, includes
the rules and regulations of the Commission promulgated thereunder) and will conduct its business in a manner so that it will not become subject to the Investment Company Act. 

(xxvii) Similar Offerings. Neither the Company nor any of its Affiliates, has, directly or indirectly, solicited
any offer to buy, sold or offered to sell or otherwise negotiated in respect of, or will solicit any offer to buy, sell or offer to sell or otherwise negotiate in respect of, in the United States or to any United States citizen or resident, any
security which is or would be integrated with the sale of the Securities in a manner that would require the offered Securities to be registered under the Securities Act. 

(xxviii) Rule 144A Eligibility. The Securities are eligible for resale pursuant to Rule 144A and will not
be, at the Closing Date, of the same class as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in a U.S. automated interdealer quotation system. 

(xxix) No Integration of Offerings or General Solicitation. None of the Company, its Affiliates or any person
acting on its or any of their behalf (other than the Initial Purchasers, as to whom the Company makes no representation or warranty) has, directly or indirectly, solicited any offer to buy or offered to sell, or will, directly or indirectly, solicit
any offer to buy or offer to sell, in the United States or to any United States citizen or resident, any security which is or would be integrated with the sale of the Securities in a manner that would require the Securities to be registered under
the Securities Act. None of the Company, its Affiliates, or any person acting on its or any of their behalf (other than the Initial Purchasers, as to whom the Company makes no representation or warranty) has engaged or will engage, in connection
with the offering of the Securities, in any form of general solicitation or general advertising within the meaning of Rule 502 under the Securities Act. 
 (xxx) No Registration Required. Subject to compliance by the Initial Purchasers with the procedures set forth in Section 6 hereof, it is not necessary in connection with the offer, sale and
delivery of the Securities to the Initial Purchasers and to each Subsequent Purchaser in the manner contemplated by this Agreement and the Offering Memorandum to register the Securities under the Securities Act or to qualify the Indenture under the
Trust Indenture Act of 1939, as amended (the “Trust Indenture Act,” which term, as used herein, includes the rules and regulations of the Commission promulgated thereunder). 

(xxxi) No Directed Selling Efforts. With respect to those offered Securities sold in reliance on Regulation S,
(A) none of the Company, its Affiliates or any person acting on its or their behalf (other than the Initial Purchasers, as to whom the Company makes no representation) has engaged or will engage in any directed selling efforts within the
meaning of Regulation S and (B) each of the Company and its Affiliates and any person acting on its or their behalf (other than the Initial Purchasers, as to whom the Company makes no representation) has complied and will comply with the
offering restrictions requirement of Regulation S and, in connection therewith, the Pricing Disclosure Package and the Final Offering Memorandum will contain the disclosure required by Rule 902 of the Securities Act. 

  
 10 

 (xxxii) Compliance with Sections 402, 302 and 906 of the Sarbanes-Oxley
Act. There is and has been no failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the
rules and regulations promulgated in connection therewith (the “Sarbanes-Oxley Act”), including Section 402 related to loans and Sections 302 and 906 related to certifications. 

(xxxiii) Payment of Taxes. The Company and the Subsidiaries have filed all federal, state, local and foreign income
and franchise tax returns required to be filed through the date hereof or have properly requested extensions thereof, except in any case in which the failure so to file would not have a Material Adverse Effect and except as set forth in or
contemplated in the Pricing Disclosure Package and the Final Offering Memorandum, and have paid all taxes required to be paid by any of them, to the extent that any such tax is due and payable, except for any such assessment that is currently being
contested in good faith or as would not have a Material Adverse Effect and except as set forth in or contemplated in the Pricing Disclosure Package and the Final Offering Memorandum. The charges, accruals and reserves on the books of the Company in
respect of any income and corporation tax liability for any years not finally determined are adequate to meet any assessments or re-assessments for additional income tax for any years not finally determined, except to the extent of any inadequacy
that would not result in a Material Adverse Effect. 
 (xxxiv) Internal Accounting Control. The Company
and the Subsidiaries maintain a system of internal accounting controls that is in compliance with the Sarbanes-Oxley Act and is sufficient to provide reasonable assurances that (A) transactions are executed in accordance with management’s
general or specific authorization, (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to maintain accountability for assets, (C) access
to assets is permitted only in accordance with management’s general or specific authorization and (D) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with
respect to any differences. 
 (xxxv) Disclosure Controls and Procedures. The Company has
established and maintains disclosure controls and procedures (as such term is defined in Rules 13a-15 and 15d-15 under the Exchange Act); such disclosure controls and procedures are designed to ensure that material information relating to the
Company and its subsidiaries is made known to the chief executive officer and chief financial officer of the Company by others within the Company or any of its subsidiaries, and such disclosure controls and procedures are reasonably effective to
perform the functions for which they were established subject to the limitations of any such control system; the Company’s auditors and the Audit Committee of the Board of Directors of the Company have been advised of: (i) any significant
deficiencies or material weaknesses in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize, and report financial data; and (ii) any fraud, whether or not material,
that involves management or other employees who have a role in the Company’s internal controls; and since the date of the most recent evaluation of such disclosure controls and procedures, there have been no significant changes in internal
controls or in other factors that could significantly affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses. 

(xxxvi) Related Party Transactions. No relationship, direct or indirect, exists between or among any of the Company
or any affiliate of the Company, on the one hand, and any director, officer, member, stockholder, customer or supplier of the Company or any Affiliate of the 

  
 11 

 
Company, on the other hand, which is required by the Securities Act to be disclosed in a registration statement on Form S-1 which is not so disclosed in the Pricing Disclosure Package and the
Final Offering Memorandum. There are no outstanding loans, advances (except advances for business expenses in the ordinary course of business) or guarantees of indebtedness by the Company or any affiliate of the Company to or for the benefit of any
of the officers or directors of the Company or any affiliate of the Company or any of their respective family members. 
 (xxxvii) Insurance. The Company and the Subsidiaries carry or are entitled to the benefits of insurance, with reputable insurers of recognized financial responsibility, in such amounts and with
such deductibles and covering such risks as are reasonable in the businesses in which they are engaged, and all such insurance is in full force and effect. The Company has no reason to believe that it or any Subsidiary will not be able (i) to
renew its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not
result in a Material Adverse Effect. Neither the Company nor any Subsidiary has been denied any insurance coverage which it has sought or for which it has applied. 

(xxxviii) Absence of Registration Rights. There are no persons with registration rights or other similar rights to
have any securities (other than the Securities) of the Company registered with the Commission. 
 (xxxix)
Solvency. The Company is, and immediately after the Closing Date (as defined in Section 2(b) hereof) will be, Solvent. As used herein, the term “Solvent” means, with respect to the Company on a particular date, that on such
date (A) the fair market value of the assets of the Company is greater than the total amount of liabilities (including contingent liabilities) of the Company, (B) the present fair salable value of the assets of the Company is greater than
the amount that will be required to pay the probable liabilities of the Company on its debts as they become absolute and matured, (C) the Company is able to realize upon its assets and pay its debts and other liabilities, including contingent
obligations, as they mature, and (D) the Company does not have unreasonably small capital. 
 (xl) No
Distribution of Unauthorized Materials. The Company has not distributed and, prior to the later to occur of (i) the Closing Date (as defined in Section 2(b) hereof) and (ii) completion of the distribution of the Securities, will
not distribute any offering material in connection with the offering and sale of the Securities other than the Offering Memorandum or other materials, if any, approved by the Representative. 

(xli) No Unlawful Contributions or Other Payments. Neither the Company nor any Subsidiary nor, to the knowledge of
the Company, any director, officer, agent, employee or Affiliate of the Company or any Subsidiary is aware of or has taken any action, directly or indirectly, that would result in a violation by such persons of the FCPA (as defined below),
including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift,
promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in
contravention of the FCPA and the Company, its Subsidiaries and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure,
and which are reasonably expected to continue to ensure, continued compliance therewith. 

  
 12 

 “FCPA” means Foreign Corrupt Practices Act of 1977, as amended, and the rules and
regulations thereunder. 
 (xlii) No Conflict with Money Laundering Laws. The operations of the
Company and the Subsidiaries are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering
statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the “Money Laundering
Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the best
knowledge of the Company, threatened. 
 (xliii) No Conflict with OFAC Laws. Neither the Company
nor any of the Subsidiaries nor, to the knowledge of the Company, any director, officer, agent, employee or affiliate of the Company or any of the Subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or
other person or entity, for the purpose of financing the activities of any person currently subject to any U.S. sanctions administered by OFAC. 
 (xliv) Regulation S. The Company and its Affiliates and all persons acting on their behalf (other than the Initial Purchasers, as to whom the Company make no representation) have complied with and
will comply with the offering restrictions requirements of Regulation S in connection with the offering of the Securities outside the United States and, in connection therewith, the Offering Memorandum will contain the disclosure required by
Rule 902. The Company is a “reporting issuer”, as defined in Rule 902 under the Securities Act. 
 (xlv) Supply of Merchandise. No supplier of merchandise to the Company or any Subsidiary has ceased shipments of merchandise to the Company or any Subsidiary, other than in the normal and ordinary
course of business consistent with past practices, which cessation would not result in a Material Adverse Effect. 
 (xlvi) Tender Offer and Consent Solicitation. As of the date on which the Supplemental Indenture (as defined below) is executed, the Company shall have received such number of Consents irrevocably
deposited pursuant to the Tender Offer and Consent Solicitation as is necessary to amend the Senior Notes Indenture as contemplated by the Tender Offer and Consent Solicitation and, as of the Closing Date, the Company shall have entered into a
supplemental indenture (the “Supplemental Indenture”) amending the Senior Notes Indenture as contemplated in the Tender Offer and Consent Solicitation. 

(xlvii) Material Agreements. The agreements, contracts or instruments listed in Exhibit C attached hereto are, as
of the date hereof, the only material agreements, contracts or instruments that are binding upon the Company and its subsidiaries on the date hereof that are material to the operation of the business of the Company and its subsidiaries. 

(b) Officer’s Certificates. Any certificate signed by any officer of the Company or any of its Subsidiaries delivered to the
Representative or to counsel for the Initial Purchasers shall be deemed a representation and warranty by the Company to each Initial Purchaser as to the matters covered thereby. 

  
 13 

 SECTION 2. Sale and Delivery to Initial Purchasers; Closing. 

(a) Securities. On the basis of the representations and warranties herein contained and subject to the terms and conditions herein
set forth, the Company agrees to sell to each Initial Purchaser, severally and not jointly, and each Initial Purchaser, severally and not jointly, agrees to purchase from the Company, at the price set forth in Schedule B, the aggregate
principal amount of Securities set forth in Schedule A opposite the name of such Initial Purchaser, plus any additional principal amount of Securities which such Initial Purchaser may become obligated to purchase pursuant to the provisions of
Section 11 hereof. 
 (b) Payment. Payment of the purchase price for, and delivery of certificates for, the
Securities shall be made at the office of Shearman & Sterling LLP, 599 Lexington Avenue, New York, NY 10022, or at such other place as shall be agreed upon by the Representative and the Company, at 9:00 A.M. (Eastern time) on the
seventh business day after the date hereof (unless postponed in accordance with the provisions of Section 11), or at such other time not later than ten business days after such date as shall be agreed upon by the Representative and the Company
(such time and date of payment and delivery being herein called the “Closing Date”). 
 Payment shall be made to the
Company by wire transfer of immediately available funds to a bank account designated by the Company, against delivery to the Representative for the respective accounts of the Initial Purchasers of certificates for the Securities to be purchased by
them. It is understood that each Initial Purchaser has authorized the Representative, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Securities which it has agreed to purchase. Merrill Lynch,
individually and not as representative of the Initial Purchasers, may (but shall not be obligated to) make payment of the purchase price for the Securities to be purchased by any Initial Purchaser whose funds have not been received by Closing Date,
but such payment shall not relieve such Initial Purchaser from its obligations hereunder. 
 (c) Denominations;
Registration. Certificates for the Securities shall be in such denominations ($2,000 or integral multiples of $1,000 in excess thereof) and registered in such names as the Representative may request in writing at least one full business day
before the Closing Date. The certificates representing the Securities shall be made available for examination and packaging by the Initial Purchasers in The City of New York not later than 10:00 A.M. on the last business day prior to Closing
Date. 
 SECTION 3. Covenants of the Company. The Company covenants with each Initial Purchaser as follows: 

(a) Offering Memorandum. The Company, as promptly as possible, will furnish to each Initial Purchaser, without charge, such number
of copies of the Offering Memorandum and any amendments and supplements thereto as such Initial Purchaser may reasonably request. 
 (b) Notice and Effect of Material Events. The Company will immediately notify each Initial Purchaser and confirm such notice in writing (x) of any filing made by the Company of information
relating to the offering of the Securities with any securities exchange or any other regulatory body in the United States or any other jurisdiction, and (y) prior to the completion of the placement of the offered Securities by the Initial
Purchasers as evidenced by a notice in writing from the Initial Purchasers to the Company, of any material changes in or affecting the condition, financial or otherwise, or the earnings, 

  
 14 

 
business affairs or business prospects of the Company and the Subsidiaries considered as one enterprise which (i) make any statement in the Pricing Disclosure Package, any Offering
Memorandum or any Company Additional Written Communication false or misleading or (ii) are not disclosed in the Pricing Disclosure Package or the Offering Memorandum. In such event or if during such time any event shall occur as a result of
which it is necessary, in the reasonable opinion of any of the Company, its counsel, the Initial Purchasers or counsel for the Initial Purchasers, to amend or supplement the Offering Memorandum in order that the Offering Memorandum not include any
untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances then existing, the Company will forthwith amend or supplement the Offering
Memorandum by preparing and furnishing to each Initial Purchaser an amendment or amendments of, or a supplement or supplements to, the Offering Memorandum (in form and substance satisfactory in the reasonable opinion of counsel for the Initial
Purchasers) so that, as so amended or supplemented, the Offering Memorandum will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
existing at the time it is delivered to a Subsequent Purchaser, not misleading. 
 Following the consummation of the Exchange
Offer or the effectiveness of an applicable shelf registration statement and for so long as the Securities are outstanding, if, in the judgment of the Representative, the Initial Purchasers or any of their affiliates (as such term is defined in the
Securities Act) are required to deliver a prospectus in connection with sales of, or market-making activities with respect to, the Securities, the Company agrees to periodically amend the applicable registration statement so that the information
contained therein complies with the requirements of Section 10 of the Securities Act, to amend the applicable registration statement or supplement the related prospectus or the documents incorporated therein when necessary to reflect any
material changes in the information provided therein so that the registration statement and the prospectus will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein,
in the light of the circumstances existing as of the date the prospectus is so delivered, not misleading and to provide the Initial Purchasers with copies of each amendment or supplement filed and such other documents as the Initial Purchasers may
reasonably request. 
 The Company hereby expressly acknowledges that the indemnification and contribution provisions of
Sections 7 and 8 hereof are specifically applicable and relate to each offering memorandum, registration statement, amendment or supplement referred to in this Section 3(b). 

(c) Amendment and Supplements to the Offering Memorandum; Preparation of Pricing Supplement; Company Additional Written Communications.
The Company will advise each Initial Purchaser promptly of any proposal to amend or supplement the Offering Memorandum and will not effect such amendment or supplement without the consent of the Initial Purchasers, which consent shall not be
unreasonably withheld. Neither the consent of the Initial Purchasers, nor the Initial Purchaser’s delivery of any such amendment or supplement, shall constitute a waiver of any of the conditions set forth in Section 5 hereof. The Company
will prepare the Pricing Supplement, in form and substance satisfactory to the Representative, and shall furnish prior to the Time of Sale to each Initial Purchaser, without charge, as many copies of the Pricing Supplement as such Initial Purchaser
may reasonably request. Before making, preparing, using, authorizing, approving or distributing any Company Additional Written Communication, the Company will furnish to the Representative a copy of such written communication for review and will not
make, prepare, use, authorize or distribute any such written communication to which the Representative reasonably objects. 

(d) Qualification of Securities for Offer and Sale. The Company will use its reasonable best efforts, in cooperation with the
Initial Purchasers, to qualify the offered Securities for offering and sale under the applicable Blue Sky or securities laws of such states and other jurisdictions as the Initial 

  
 15 

 
Purchasers may designate and to maintain such qualifications in effect as long as required for the sale of the Securities; provided, however, that the Company shall not be obligated
to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any
jurisdiction in which it is not otherwise so subject. 
 (e) Rating of Securities. The Company shall take all reasonable
action necessary to enable Standard & Poor’s Ratings Services, a division of McGraw Hill, Inc. (“S&P”), and Moody’s Investors Service Inc. (“Moody’s”) to provide their respective credit ratings of the
Securities. 
 (f) DTC. The Company will cooperate with the Initial Purchasers and use its reasonable best efforts to
permit the offered Securities to be eligible for clearance and settlement through the facilities of DTC. 
 (g) Use of
Proceeds. The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in the Offering Memorandum under “Use of Proceeds”. 

(h) Restriction on Sale of Securities. Except with respect to Exchange Securities offered and issued pursuant to the Registration
Rights Agreement, during a period of 90 days from the date of the Offering Memorandum, the Company will not, without the prior written consent of Merrill Lynch, directly or indirectly, issue, sell, offer or agree to sell, grant any option for the
sale of, or otherwise dispose of, any other debt securities of the Company or securities of the Company that are convertible into, or exchangeable for, the offered Securities or such other debt securities. 

(i) Reporting Requirements. Until the offering of the Securities is complete, the Company will file all documents required to be
filed with the Commission pursuant to the Exchange Act within the time periods required by the Exchange Act and the Exchange Act Regulations. 
 (j) Senior Notes. To the extent the Company has delivered a Notice of Redemption (defined below) as described in Section 5(k) hereof, the Company shall deposit with the Paying Agent (as such
term is defined in the Senior Notes Indenture) such funds that are sufficient to redeem all Senior Notes that remain outstanding following the completion of the Tender Offer and Consent Solicitation in the manner provided in the Senior Notes
Indenture. 
 SECTION 4. Payment of Expenses. 
 (a) Expenses. The Company agrees to pay all costs, fees and expenses incurred in connection with the performance of its obligations hereunder and in connection with the transactions contemplated
hereby, including, without limitation, (i) all expenses incident to the issuance and delivery of the Securities (including all printing and engraving costs), (ii) all necessary issue, transfer and other stamp taxes in connection with the
issuance and sale of the Securities to the Initial Purchasers, (iii) all fees and expenses of the Company’s counsel, independent public or certified public accountants and other advisors, (iv) all costs and expenses incurred in
connection with the preparation, printing, filing, shipping and distribution of the Pricing Disclosure Package and the Final Offering Memorandum (including financial statements and exhibits), and all amendments and supplements thereto, and the
Transaction Documents, (v) all filing fees, attorneys’ fees and expenses incurred by the Company or the Initial Purchasers in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all
or any part of the Securities for offer and sale under the securities laws of the several states of the United States, the provinces of Canada or other jurisdictions designated by the Initial 

  
 16 

 
Purchasers (including, without limitation, the cost of preparing, printing and mailing preliminary and final blue sky or legal investment memoranda and any related supplements to the Pricing
Disclosure Package or the Final Offering Memorandum), (vi) the fees and expenses of the Trustee, including the fees and disbursements of counsel for the Trustee in connection with the Indenture, the Securities and the Exchange Securities,
(vii) any fees payable in connection with the rating of the Securities or the Exchange Securities with the ratings agencies, (viii) any filing fees incident to, and any reasonable fees and disbursements of counsel to the Initial Purchasers
in connection with the review by the Financial Industry Regulatory Authority, Inc. (“FINRA”), if any, of the terms of the sale of the Securities or the Exchange Securities, (ix) all fees and expenses (including reasonable fees and
expenses of counsel) of the Company in connection with approval of the Securities by the Depositary for “book-entry” transfer, and the performance by the Company of its other obligations under this Agreement and (x) all expenses
incident to the “road show” for the offering of the Securities, including the cost of any chartered airplane or other transportation. 
 (b) Termination of Agreement. If this Agreement is terminated by the Representative in accordance with the provisions of Section 5 or Section 10(a)(i) hereof, the Company shall reimburse
the Initial Purchasers for all of their out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Initial Purchasers. 
 SECTION 5. Conditions of Initial Purchasers’ Obligations. The obligations of the several Initial Purchasers hereunder are subject to the accuracy of the representations and warranties of the
Company contained in Section 1 hereof or in certificates of any officer of the Company or any of its subsidiaries delivered pursuant to the provisions hereof, to the performance by the Company of its covenants and other obligations hereunder,
and to the following further conditions: 
 (a) Opinion of Counsel for Company. At the Closing Date, the Representative
shall have received the favorable opinion, dated as of the Closing Date, of Skadden, Arps, Slate, Meagher & Flom LLP, counsel for the Company, in form and substance reasonably satisfactory to counsel for the Initial Purchasers, together
with signed or reproduced copies of such letter for each of the other Initial Purchasers, substantially to the effect set forth in Exhibit A hereto. 
 (b) Opinion of Counsel for Company. At the Closing Date, the Representative shall have received the favorable opinion, dated as of the Closing Date, of Honigman Miller Schwartz and Cohn LLP,
counsel for the Company, in form and substance reasonably satisfactory to counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers, substantially to the effect set forth in
Exhibit B hereto. 
 (c) Opinion of Counsel for Initial Purchasers. At the Closing Date, the Representative shall
have received the favorable opinion, dated as of the Closing Date, of Shearman & Sterling LLP, counsel for the Initial Purchasers, together with signed or reproduced copies of such letter for each of the other Initial Purchasers
satisfactory to the Initial Purchasers. 
 (d) Officers’ Certificate. At the Closing Date, there shall not have
been, since the date hereof or since the date as of which information is given in the Final Offering Memorandum (exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), any material adverse change in the
condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, and the Representative shall
have received a certificate of the President or a Vice President of the Company and of the chief financial or chief accounting officer of the Company, dated as 

  
 17 

 
of the Closing Date, to the effect that (i) there has been no such material adverse change, (ii) the representations and warranties in Section 1 hereof are true and correct with
the same force and effect as though expressly made at and as of the Closing Date, and (iii) the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Date.

 (e) Accountants’ Comfort Letter. On the date hereof, the Representative shall have received from KPMG LLP a
letter dated such date, in form and substance satisfactory to the Representative, together with signed or reproduced copies of such letter for each of the other Initial Purchasers containing statements and information of the type ordinarily included
in accountants’ “comfort letters” to Initial Purchasers with respect to the financial statements and certain financial information contained in the Offering Memorandum. 

(f) Bring-down Comfort Letter. At the Closing Date, the Representative shall have received from KPMG LLP a letter, dated as of the
Closing Date, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e) of this Section, except that the specified date referred to shall be a date not more than three business days prior to the
Closing Date. 
 (g) Maintenance of Rating. Since the date of this Agreement, there shall not have occurred a downgrading
in the rating assigned to the Securities by any “nationally recognized statistical rating agency”, as that term is defined by the Commission for purposes of Rule 436(g)(2) under the Securities Act, and no such securities rating agency
shall have publicly announced that it has under surveillance or review, with possible negative implications, its rating of the Securities or any of the Company’s other debt securities. 

(h) Indenture. At the Closing Date, the Company and the Trustee shall have entered into the Indenture and the Initial Purchasers
shall have received executed counterparts thereof. 
 (i) Registration Rights Agreement. At the Closing Date, the Company
shall have entered into the Registration Rights Agreement and the Initial Purchasers shall have received executed counterparts thereof. 
 (j) Additional Documents. At the Closing Date, counsel for the Initial Purchasers shall have been furnished with such documents and opinions as they may reasonably request for the purpose of
enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions herein contained; and all
proceedings taken by the Company in connection with the issuance and sale of the Securities as herein contemplated shall be satisfactory in form and substance to the Representative and counsel for the Initial Purchasers. 

(k) Senior Notes. The Senior Notes Indenture shall have been amended as contemplated by the terms of the Tender Offer and Consent
Solicitation. To the extent that any Senior Notes remain outstanding following the repurchase of the Senior Notes pursuant to the terms of the Tender Offer and Consent Solicitation, the Company shall have delivered to The Bank of New York, the
trustee under the Senior Notes Indenture, irrevocable notice of redemption (the “Notice of Redemption”) of all such Senior Notes that remain outstanding, as provided by Article Three of the Senior Notes Indenture. 

(l) Termination of Agreement. If any condition specified in this Section shall not have been fulfilled when and as required to be
fulfilled, this Agreement may be terminated by the Representative by notice to the Company at any time at or prior to the Closing Date, and such termination shall be without 

  
 18 

 
liability of any party to any other party except as provided in Section 4 and except that Sections 7 and 8 shall survive any such termination and remain in full force and effect.

 SECTION 6. Subsequent Offers and Resales of the Securities. 

(a) Offer and Sale Procedures. Each of the Initial Purchasers and the Company hereby establish and agree to observe the following
procedures in connection with the offer and sale of the Securities: 
 (i) Offers and Sales. Offers and
sales of the Securities shall be made to such persons and in such manner as is contemplated by the Offering Memorandum. Each Initial Purchaser severally agrees that it will not offer, sell or deliver any of the Securities in any jurisdiction outside
the United States except under circumstances that will result in compliance with the applicable laws thereof, and that it will take at its own expense whatever action is required to permit its purchase and resale of the Securities in such
jurisdictions. 
 (ii) No General Solicitation. No general solicitation or general advertising (within the
meaning of Rule 502(c) under the Securities Act) will be used in the United States in connection with the offering or sale of the Securities. 
 (iii) Purchases by Non-Bank Fiduciaries. In the case of a non-bank Subsequent Purchaser of a Security acting as a fiduciary for one or more third parties, each third party shall, in the judgment of
the applicable Initial Purchaser, be a “qualified institutional buyer” within the meaning of Rule 144A under the Securities Act (a “Qualified Institutional Buyer”) or a non-U.S. person outside the United States. 

(iv) Subsequent Purchaser Notification. Each Initial Purchaser will take reasonable steps to inform, and cause each
of its U.S. affiliates to take reasonable steps to inform, persons acquiring Securities from such Initial Purchaser or affiliate, as the case may be, in the United States that the Securities (A) have not been and will not be registered under
the Securities Act, (B) are being sold to them without registration under the Securities Act in reliance on Rule 144A or in accordance with another exemption from registration under the Securities Act, as the case may be, and (C) may
not be offered, sold or otherwise transferred, except (1) to the Company, (2) outside the United States in accordance with Regulation S, or (3) inside the United States (x) in accordance with Rule 144A to a person whom
the seller reasonably believes is a Qualified Institutional Buyer that is purchasing such Securities for its own account or for the account of a Qualified Institutional Buyer to whom notice is given that the offer, sale or transfer is being made in
reliance on Rule 144A or (y) pursuant to another available exemption from registration under the Securities Act. 
 (v) Minimum Principal Amount. No sale of the Securities to any one Subsequent Purchaser will be for less than U.S. $2,000 principal amount and no Security will be issued in a smaller principal
amount. If the Subsequent Purchaser is a non-bank fiduciary acting on behalf of others, each person for whom it is acting must purchase at least U.S. $2,000 principal amount of the Securities. 

(b) Covenants of the Company. The Company covenants with each Initial Purchaser as follows: 

(i) Integration. The Company agrees that it will not and will cause its Affiliates not to, directly or indirectly,
solicit any offer to buy, sell or make any offer or sale of, or otherwise 

  
 19 

 
negotiate in respect of, securities of the Company of any class if, as a result of the doctrine of “integration” referred to in Rule 502 under the Securities Act, such offer or
sale would render invalid (for the purpose of (i) the sale of the offered Securities by the Company to the Initial Purchasers, (ii) the resale of the offered Securities by the Initial Purchasers to Subsequent Purchasers or (iii) the
resale of the offered Securities by such Subsequent Purchasers to others) the exemption from the registration requirements of the Securities Act provided by Section 4(2) thereof or by Rule 144A or by Regulation S thereunder or
otherwise. 
 (ii) Rule 144A Information. The Company agrees that, in order to render the offered
Securities eligible for resale pursuant to Rule 144A under the Securities Act, while any of the offered Securities remain outstanding and are “restricted securities” within the meaning of Rule 144(a)(3) of the Securities Act, it will
make available, upon request, to any holder of offered Securities or prospective purchasers of Securities the information specified in Rule 144A(d)(4), unless the Company furnishes information to the Commission pursuant to Section 13 or
15(d) of the Exchange Act. 
 (iii) Restriction on Repurchases. Until the expiration of one year after the
original issuance of the offered Securities, the Company will not, and will cause its Affiliates not to, resell any Securities which are “restricted securities” (as such term is defined under Rule 144(a)(3) under the Securities Act),
whether as beneficial owner or otherwise (except as agent acting as a securities broker on behalf of and for the account of customers in the ordinary course of business in unsolicited broker’s transactions). 

(c) Qualified Institutional Buyer. Each Initial Purchaser severally and not jointly represents and warrants to, and agrees with,
the Company that it is a Qualified Institutional Buyer. 
 Resale Pursuant to Rule 903 of Regulation S or Rule 144A. Each
Initial Purchaser understands that the Securities have not been and will not be registered under the Securities Act and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except in accordance
with Regulation S under the Securities Act or pursuant to an exemption from the registration requirements of the Securities Act. Each Initial Purchaser severally represents and agrees, that, except as permitted by Section 6(a) above, it
has offered and sold Securities and will offer and sell Securities (i) as part of their distribution at any time and (ii) otherwise until forty days after the later of the date upon which the offering of the Securities commences and the
Closing Date, only in accordance with Rule 903 of Regulation S, Rule 144A under the Securities Act or another applicable exemption from the registration requirements of the Securities Act. Accordingly, neither the Initial Purchasers,
their affiliates nor any persons acting on their behalf have engaged or will engage in any directed selling efforts with respect to Securities sold hereunder pursuant to Regulation S, and the Initial Purchasers, their affiliates and any person
acting on their behalf have complied and will comply with the offering restriction requirements of Regulation S. Each Initial Purchaser severally agrees that, at or prior to confirmation of a sale of offered Securities pursuant to
Regulation S it will have sent to each distributor, dealer or person receiving a selling concession, fee or other remuneration that purchases offered Securities from it or through it during the restricted period a confirmation or notice to
substantially the following effect: 
 “The Securities covered hereby have not been registered under the United States
Securities Act of 1933 (the “Securities Act”) and may not be offered or sold within the United States or to or for the account or benefit of U.S. persons (i) as part of their distribution at any time and (ii) otherwise until
forty days after the later of the date upon which the offering of the Securities commenced and the date of closing, except in either case in 

  
 20 

 
accordance with Regulation S or Rule 144A under the Securities Act. Terms used above have the meaning given to them by Regulation S.” 

Terms used in the above paragraph have the meanings given to them by Regulation S. 

SECTION 7. Indemnification. 
 (a) Indemnification of the Initial Purchasers. The Company agrees to indemnify and hold harmless each Initial Purchaser, its affiliates, directors, officers and employees, and each person, if any,
who controls any Initial Purchaser within the meaning of the Securities Act and the Exchange Act against any loss, claim, damage, liability or expense, as incurred, to which such Initial Purchaser, affiliate, director, officer, employee or
controlling person may become subject, under the Securities Act, the Exchange Act or other federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with
the written consent of the Company), insofar as such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based: (i) upon any untrue statement or alleged untrue statement of a
material fact contained in the Preliminary Offering Memorandum, the Pricing Supplement, any Company Additional Written Communication or the Final Offering Memorandum (or any amendment or supplement thereto), or the omission or alleged omission
therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (ii) any act or failure to act or any alleged act or failure to act by any Initial
Purchaser in connection with, or relating in any manner to, the offering contemplated hereby, and which is included as part of or referred to in any loss, claim, damage, liability or action arising out of or based upon any matter covered by clause
(i) above, provided that the Company shall not be liable under this clause (ii) to the extent that a court of competent jurisdiction shall have determined by a final judgment that such loss, claim, damage, liability or action resulted
directly from any such acts or failures to act undertaken or omitted to be taken by such Initial Purchaser through its gross negligence or willful misconduct; and to reimburse each Initial Purchaser and each such affiliate, director, officer,
employee or controlling person for any and all expenses (including the fees and disbursements of counsel chosen by Merrill Lynch) as such expenses are reasonably incurred by such Initial Purchaser or such affiliate, director, officer, employee or
controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense or action; provided, however, that the foregoing indemnity agreement shall not apply, with respect to
an Initial Purchaser, to any loss, claim, damage, liability or expense to the extent, but only to the extent, arising out of or based upon any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in
conformity with written information furnished to the Company by such Initial Purchaser through the Representative expressly for use in the Preliminary Offering Memorandum, the Pricing Supplement, any Company Additional Written Communication or the
Final Offering Memorandum (or any amendment or supplement thereto). The indemnity agreement set forth in this Section 7(a) shall be in addition to any liabilities that the Company may otherwise have. 

(b) Indemnification of the Company. Each Initial Purchaser agrees, severally and not jointly, to indemnify and hold harmless the
Company, its directors and each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act, against any loss, claim, damage, liability or expense, as incurred, to which the Company or any such director or
controlling person may become subject, under the Securities Act, the Exchange Act, or other federal or state statutory law or regulation, or at common law or otherwise (including in settlement of any litigation, if such settlement is effected with
the written consent of such Initial Purchaser), insofar as such loss, claim, damage, liability 

  
 21 

 
or expense (or actions in respect thereof as contemplated below) arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in the Preliminary
Offering Memorandum, the Pricing Supplement, any Company Additional Written Communication or the Final Offering Memorandum (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission
was made in the Preliminary Offering Memorandum, the Pricing Supplement, any Company Additional Written Communication or the Final Offering Memorandum (or any amendment or supplement thereto), in reliance upon and in conformity with written
information furnished to the Company by such Initial Purchaser through the Representative expressly for use therein; and to reimburse the Company and each such director or controlling person for any and all expenses (including the fees and
disbursements of counsel) as such expenses are reasonably incurred by the Company or such director or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage, liability, expense
or action. The Company hereby acknowledges that the only information that the Initial Purchasers through the Representative have furnished to the Company expressly for use in the Preliminary Offering Memorandum, the Pricing Supplement, any Company
Additional Written Communication or the Final Offering Memorandum (or any amendment or supplement thereto) are the statements set forth in the first and second paragraphs under the caption “Plan of Distribution—Short Positions” in the
Preliminary Offering Memorandum and the Final Offering Memorandum. The indemnity agreement set forth in this Section 7(b) shall be in addition to any liabilities that each Initial Purchaser may otherwise have. 

(c) Notifications and Other Indemnification Procedures. Promptly after receipt by an indemnified party under this Section 7
of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this Section 7, notify the indemnifying party in writing of the commencement thereof;
provided that the failure to so notify the indemnifying party will not relieve it from any liability which it may have to any indemnified party under this Section 7 except to the extent that it has been materially prejudiced by such failure
(through the forfeiture of substantive rights and defenses) and shall not relieve the indemnifying party from any liability that the indemnifying party may have to an indemnified party other than under this Section 7. In case any such action is
brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in and, to the extent that it shall elect, jointly with all other
indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel reasonably satisfactory to such
indemnified party; provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably concluded that a conflict may arise between the positions of the
indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the
indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such indemnified party or parties. Upon
receipt of notice from the indemnifying party to such indemnified party of such indemnifying party’s election so to assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will not be liable to
such indemnified party under this Section 7 for any legal or other expenses subsequently incurred by such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have employed separate counsel in
accordance with the proviso to the immediately preceding sentence (it being understood, however, that the indemnifying party shall not be liable for the expenses of more than one separate counsel (together with local counsel (in each jurisdiction)),
which shall be selected by Merrill Lynch (in the case of counsel representing the Initial 

  
 22 

 
Purchasers or their related persons), representing the indemnified parties who are parties to such action) or (ii) the indemnifying party shall not have employed counsel satisfactory to the
indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the action, in each of which cases the fees and expenses of counsel shall be at the expense of the indemnifying party. 

(d) Settlements. The indemnifying party under this Section 7 shall not be liable for any settlement of any proceeding
effected without its written consent, which will not be unreasonably withheld, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss,
claim, damage, liability or expense by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and
expenses of counsel as contemplated by this Section 7, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i) such settlement is entered into more than 30 days
after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying party
shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could
have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent (i) includes an unconditional release of such indemnified party from all liability on claims that
are the subject matter of such action, suit or proceeding and (ii) does not include any statements as to or any findings of fault, culpability or failure to act by or on behalf of any indemnified party. 

SECTION 8. Contribution. If the indemnification provided for in Section 7 hereof is for any reason unavailable to or
insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims,
damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Initial Purchasers on the other hand from the
offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause (i) above but also the relative fault of the Company on the one hand and of the Initial Purchasers on the other hand in connection with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses,
as well as any other relevant equitable considerations. 
 The relative benefits received by the Company on the one hand and the
Initial Purchasers on the other hand in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to this
Agreement (before deducting expenses) received by the Company and the total underwriting discount received by the Initial Purchasers, bear to the aggregate initial offering price of the Securities. 

The relative fault of the Company on the one hand and the Initial Purchasers on the other hand shall be determined by reference to, among
other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the Initial Purchasers and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. 

  
 23 

 The amount paid or payable by a party as a result of the losses, claims, damages,
liabilities and expenses referred to above shall be deemed to include, subject to the limitations set forth in Section 7 hereof, any legal or other fees or expenses reasonably incurred by such party in connection with investigating or defending
any action or claim. The provisions set forth in Section 7 hereof with respect to notice of commencement of any action shall apply if a claim for contribution is to be made under this Section 8; provided, however, that no additional notice
shall be required with respect to any action for which notice has been given under Section 7 hereof for purposes of indemnification. 
 The Company and the Initial Purchasers agree that it would not be just and equitable if contribution pursuant to this Section 8 were determined by pro rata allocation (even if the Initial Purchasers
were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to in this Section 8. 

Notwithstanding the provisions of this Section 8, no Initial Purchaser shall be required to contribute any amount in excess of the
discount received by such Initial Purchaser in connection with the Securities distributed by it. No person guilty of fraudulent misrepresentation (within the meaning of Section 11 of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. The Initial Purchasers’ obligations to contribute pursuant to this Section 8 are several, and not joint, in proportion to their respective commitments as set forth
opposite their names in Schedule A. For purposes of this Section 8, each director, officer and employee of an Initial Purchaser and each person, if any, who controls an Initial Purchaser within the meaning of the Securities Act and the Exchange
Act shall have the same rights to contribution as such Initial Purchaser, and each director of the Company, and each person, if any, who controls the Company within the meaning of the Securities Act and the Exchange Act shall have the same rights to
contribution as the Company. 
 SECTION 9. Representations, Warranties and Agreements to Survive. All representations,
warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its subsidiaries submitted pursuant hereto shall remain operative and in full force and effect, regardless of (i) any investigation
made by or on behalf of any Initial Purchaser or Initial Purchaser Affiliate or selling agents, any person controlling any Initial Purchaser, its officers or directors or any person controlling the Company and (ii) delivery of and payment for
the Securities. 
 SECTION 10. Termination of Agreement. 

(a) Termination; General. The Representative may terminate this Agreement, by notice to the Company, at any time at or prior to
the Closing Date (i) if there has been, since the time of execution of this Agreement or since the date as of which information is given in the Preliminary Offering Memorandum, the Pricing Disclosure Package or the Final Offering Memorandum
(exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, or (ii) the Company shall have sustained a loss by strike, fire, flood, earthquake, accident or other calamity of such character as in the
judgment of the Representative may interfere materially with the conduct of the business and operations of the Company regardless of whether or not such loss shall have been insured, or (iii) if there has occurred any material adverse change in
the financial markets in the United States or the international financial markets, any outbreak of hostilities or escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international
political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the Representative, impracticable or inadvisable to market 

  
 24 

 
the Securities or to enforce contracts for the sale of the Securities, or (iv) if trading in any securities of the Company has been suspended or materially limited by the Commission or the
NASDAQ Stock Market, or if trading generally on the New York Stock Exchange or the NASDAQ Stock Market has been suspended or materially limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been
required, by said exchange or by such market or by order of the Commission, FINRA or any other governmental authority, or (v) if a material disruption has occurred in commercial banking or securities settlements or clearance services in the
United States or (vi) if a banking moratorium has been declared by either Federal, New York or Delaware authorities. 
 (b)
Liabilities. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except as provided in Section 4 hereof, and provided further that
Sections 7 and 8 shall survive such termination and remain in full force and effect. 
 SECTION 11. Default by One or
More of the Initial Purchasers. If one or more of the Initial Purchasers shall fail at the Closing Date to purchase the Securities which it or they are obligated to purchase under this Agreement (the “Defaulted Securities”), the
Representative shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Initial Purchasers, or any other initial purchasers, to purchase all, but not less than all, of the Defaulted Securities
in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representative shall not have completed such arrangements within such 24-hour period, then: 

(a) if the number of Defaulted Securities does not exceed 10% of the aggregate principal amount of the Securities to be
purchased hereunder, each of the non-defaulting Initial Purchasers shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting obligations hereunder bear to the
underwriting obligations of all non-defaulting Initial Purchasers, or 
 (b) if the number of Defaulted
Securities exceeds 10% of the aggregate principal amount of the Securities to be purchased hereunder, this Agreement shall terminate without liability on the part of any non-defaulting Initial Purchaser. 

No action taken pursuant to this Section shall relieve any defaulting Initial Purchaser from liability in respect of its default.

 In the event of any such default which does not result in a termination of this Agreement, either the Representative or the
Company shall have the right to postpone the Closing Date for a period not exceeding seven days in order to effect any required changes in the Offering Memorandum or in any other documents or arrangements. As used herein, the term “Initial
Purchaser” includes any person substituted for an Initial Purchaser under this Section 11. 
 SECTION 12. Tax
Disclosure. Notwithstanding any other provision of this Agreement, immediately upon commencement of discussions with respect to the transactions contemplated hereby, the Company (and each employee, representative or other agent of the Company)
may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Agreement and all materials of any kind (including opinions or other tax analyses) that are provided to
the Company relating to such tax treatment and tax structure. For purposes of the foregoing, the term “tax treatment” is the purported or claimed federal income tax treatment of the transactions contemplated hereby, and the term

  
 25 

 
“tax structure” includes any fact that may be relevant to understanding the purported or claimed federal income tax treatment of the transactions contemplated hereby. 

SECTION 13. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly
given if mailed or transmitted by any standard form of telecommunication. Notices to the Initial Purchasers shall be directed to the Representative at One Bryant Park, New York, New York 10036, Facsimile No. (917) 267-7085, attention of HY
Legal, notices to the Company shall be directed to it at AEP Industries Inc., 125 Phillips Avenue, South Hackensack, New Jersey 07606, Facsimile No. (201) 807-6801, attention of Paul Feeney. 

SECTION 14. No Advisory or Fiduciary Relationship. The Company acknowledges and agrees that (a) the purchase and sale of the
Securities pursuant to this Agreement, including the determination of the offering price of the Securities and any related discounts and commissions, is an arm’s-length commercial transaction between the Company, on the one hand, and the
several Initial Purchasers, on the other hand, (b) in connection with the offering contemplated hereby and the process leading to such transaction each Initial Purchaser is and has been acting solely as a principal and is not the agent or
fiduciary of the Company, or its stockholders, creditors, employees or any other party, (c) no Initial Purchaser has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering
contemplated hereby or the process leading thereto (irrespective of whether such Initial Purchaser has advised or is currently advising the Company on other matters) and no Initial Purchaser has any obligation to the Company with respect to the
offering contemplated hereby except the obligations expressly set forth in this Agreement, (d) the Initial Purchasers and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those
of each of the Company, and (e) the Initial Purchasers have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the Company has consulted its own legal, accounting, regulatory and
tax advisors to the extent it deemed appropriate. 
 SECTION 15. Integration. This Agreement supersedes all prior
agreements and understandings (whether written or oral) between the Company and the Initial Purchasers, or any of them, with respect to the subject matter hereof. 
 SECTION 16. Parties. This Agreement shall inure to the benefit of and be binding upon the Initial Purchasers and the Company and their respective successors. Nothing expressed or mentioned in this
Agreement is intended or shall be construed to give any person, firm or corporation, other than the Initial Purchasers and the Company and their respective successors and the controlling persons and officers and directors referred to in
Sections 7 and 8 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are
intended to be for the sole and exclusive benefit of the Initial Purchasers and the Company and their respective successors, and said controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no
other person, firm or corporation. No purchaser of Securities from any Initial Purchaser shall be deemed to be a successor by reason merely of such purchase. 
 SECTION 17. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 

  
 26 

 SECTION 18. TIME. TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE
SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. 
 SECTION 19. Counterparts. This Agreement may be
executed in any number of counterparts, each of which shall be deemed to be an original, but all such counterparts shall together constitute one and the same Agreement. Delivery of an executed counterpart of a signature page to this Agreement by
telecopier, facsimile or other electronic transmission (i.e., a “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart thereof. 
 SECTION 20. Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction hereof. 

  
 27 

 If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement between the Initial Purchasers and the Company in accordance with its terms. 

 

					
	Very truly yours,
	
	AEP INDUSTRIES INC.
		
	By 	 	/s/ Paul M. Feeney
		 	Name:	 	Paul M. Feeney
		 	Title:	 	Executive Vice President, Finance and Chief Financial Officer

  

			
	 CONFIRMED AND ACCEPTED,
as of the date first above written:

 
 MERRILL LYNCH, PIERCE, FENNER &
SMITH INCORPORATED

  

			
	By:	 	/s/ John Cokinos
		 	Authorized Signatory

 For itself
and as Representative of the other Initial Purchaser named in Schedule A hereto. 

  

 SCHEDULE A 
  

					
	Name of Initial Purchaser	  	Principal 
Amount of
Securities	 
	 Merrill Lynch Pierce, Fenner & Smith Incorporated
	  	$	160,000,000	  
	 Wells Fargo Securities, LLC
	  	 	40,000,000	  
		  	 	 	 
	 Total
	  	$	200,000,000	  
		  	 	 	 

  
 Sch A-1

 SCHEDULE B 
 AEP INDUSTRIES INC. 
 $200,000,000 Senior Notes 

1. The initial public offering price of the Securities shall be 100.000% of the principal amount thereof, plus accrued interest, if any,
from the date of issuance. 
 2. The purchase price to be paid by the Initial Purchasers for the Securities shall be 98.000% of
the principal amount thereof. 
 3. The interest rate on the Securities shall be 8.250% per annum. 

  
 Sch B-1

 SCHEDULE C 
 List of Subsidiaries 
  

					
	 Subsidiary
	  	Country of
Incorporation
	 1.
	  	AEP Canada Inc.	  	Canada
	 2.
	  	AEP Industries (NZ) Limited	  	New Zealand
	 3.
	  	AEP Industries Packaging (Espana) SA	  	Spain
	 4.
	  	AEP Industries Finance Inc.	  	United States

  
 Sch C-1

 EXHIBIT A 
 FORMS OF OPINION OF SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP, COMPANY’S 
 COUNSEL TO BE DELIVERED PURSUANT TO SECTION 5(a) 

  
 A-1

 EXHIBIT B 
 FORMS OF OPINION OF HONIGMAN MILLER SCHWARTZ AND COHN LLP, COMPANY’S 
 COUNSEL
TO BE DELIVERED PURSUANT TO SECTION 5(b) 

  
 B-1

 EXHIBIT C 
 1. Indenture, dated as of March 18, 2005, between the Company and The Bank of New York, as trustee. 
 2. First Supplemental Indenture, to be dated as of April 18, 2011, between the Company and The Bank of New York Mellon, as trustee. 

3. Asset Purchase Agreement, dated August 9, 2008, by and among Atlantis Plastics, Inc, Atlantis Plastics Films, Inc., and Linear
Films, Inc. and AEP Industries Inc. 
 4. Amended and Restated Loan and Security Agreement, dated October 30, 2008, by and
among the Company, Wells Fargo Bank, National Association, successor by merger to Wachovia Bank, National Association, as Agent, and the financial institutions party thereto. 
 5. Amended and Restated 2005 Stock Option Plan of the Company. 
 6. 1995 Stock
Option Plan of the Company. 
 7. Lease, dated as of March 20, 1990, between the Company and Huyler Assoc., L.P.

 8. Employment Agreement, dated as of November 1, 2004, between the Company and J. Brendan Barba, as amended. 

9. Employment Agreement, dated as of November 1, 2004, between the Company and Paul M. Feeney, as amended. 

10. Employment Agreement, effective as of November 1, 2004, between the Company and John J. Powers, as amended. 

11. Employment Agreement, effective as of November 1, 2004, between the Company and David J. Cron, as amended. 

12. Employment Agreement, effective as of November 1, 2004, between the Company and Paul C. Vegliante, as amended. 

13. Employment Agreement, effective as of November 1, 2004, between the Company and Lawrence R. Noll, as amended. 

14. Employment Agreement, effective as of November 1, 2008, between the Company and Linda N. Guerrera, as amended. 

15. Letter Agreement, dated February 12, 2010, among AEP Industries Inc., KSA Capital Management, LLC, Daniel D. Khoshaba and each
of the other persons set forth on the signature pages thereto. 
 16. Purchase Agreement, dated August 5, 2010, among AEP
Industries Inc., KSA Capital Management, LLC, Daniel D. Khoshaba and each of the other persons set forth on the signature pages thereto. 

  
 C-1

 17. Rights Agreement, dated as of March 31, 2011, between the Company and American
Stock Transfer & Trust Company, LLC, a New York limited liability trust company, as rights agent. 

  
 C-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00190-of-00352.parquet"}]]